日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical Significance and Therapeutic Potential of Long Non-Coding RNA H19 in Soft Tissue Sarcoma.

长链非编码RNA H19在软组织肉瘤中的临床意义和治疗潜力。

Jahn Stephan, Krajina Katarina, Smolle Maria Anna, Neufeldt Dimyana, Jonas Katharina, Rinner Beate, Mellert Kevin, Noeparast Maxim, Trepel Martin, Szkandera Joanna, Pichler Martin, Liegl-Azwanger Bernadette

Correction: Sesquiterpene lactones downregulate G2/M cell cycle regulator proteins and affect the invasive potential of human soft tissue sarcoma cells

更正:倍半萜内酯可下调 G2/M 期细胞周期调节蛋白,并影响人软组织肉瘤细胞的侵袭能力。

Lohberger, Birgit; Rinner, Beate; Stuendl, Nicole; Kaltenegger, Heike; Steinecker-Frohnwieser, Bibiane; Bernhart, Eva; Rad, Ehsan Bonyadi; Weinberg, Annelie Martina; Leithner, Andreas; Bauer, Rudolf; Kretschmer, Nadine

Proteomic and metabolomic profiling of extracellular vesicles produced by human gut archaea.

人类肠道古菌产生的细胞外囊泡的蛋白质组学和代谢组学分析

Weinberger Viktoria, Darnhofer Barbara, Thapa Himadri B, Mertelj Polona, Stentz Régis, Jones Emily, Grabmann Gerlinde, Mohammadzadeh Rokhsareh, Shinde Tejus, Karner Christina, Ober Jennifer, Juodeikis Rokas, Pernitsch Dominique, Hingerl Kerstin, Zurabishvili Tamara, Kumpitsch Christina, Kuehnast Torben, Rinner Beate, Strohmaier Heimo, Kolb Dagmar, Gotts Kathryn, Weichhart Thomas, Köcher Thomas, Köfeler Harald, Carding Simon R, Schild Stefan, Moissl-Eichinger Christine

Patient-derived tumoroids from CIC::DUX4 rearranged sarcoma identify MCL1 as a therapeutic target.

从 CIC::DUX4 重排肉瘤中分离出的患者来源的肿瘤样细胞确定 MCL1 为治疗靶点

Breunis Willemijn, Brack Eva, Ehlers Anna C, Bechtold Ingrid, Kisele Samanta, Wurth Jakob, Mous Lieke, Zabele Dorita, Steffen Fabio, Zahnow Felina, Britschgi Christian, Bankel Lorenz, Rothermundt Christian, Vetter Cornelia, Müller Daniel, Botter Sander, Pauli Chantal, Bode Peter, Rinner Beate, Bourquin Jean-Pierre, Roessler Jochen, Grünewald Thomas G P, Schäfer Beat W, Surdez Didier, Wachtel Marco

Evaluation of crizotinib as radiosensitizer in sacral chordoma cells: effects of combined carbon ion particle therapy

克唑替尼作为放射增敏剂在骶骨脊索瘤细胞中的疗效评价:联合碳离子粒子疗法的效果

Lohberger, Birgit; Glänzer, Dietmar; Etschmaier, Vanessa; Trajanoski, Slave; Leithner, Andreas; Rinner, Beate; Georg, Dietmar

Detection of a Water-Soluble Hypericin Formulation in Glioblastoma Tissue with Fluorescence Lifetime and Intensity Using a Dual-Tap CMOS Camera System

利用双抽头CMOS相机系统,通过荧光寿命和强度检测胶质母细胞瘤组织中的水溶性金丝桃素制剂

Mischkulnig, Mario; Reichert, David; Wightman, Lionel; Roth, Vanessa; Hölz, Marijke; Körner, Lisa I; Kiesel, Barbara; Vejzovic, Djenana; Giardina, Gabriel A; Erkkilae, Mikael T; Unterhuber, Angelika; Andreana, Marco; Rinner, Beate; Kubin, Andreas; Leitgeb, Rainer; Widhalm, Georg

MUG CCArly: A Novel Autologous 3D Cholangiocarcinoma Model Presents an Increased Angiogenic Potential

MUG CCArly:一种新型自体3D胆管癌模型展现出增强的血管生成潜能

Schrom, Silke; Kleinegger, Florian; Anders, Ines; Hebesberger, Thomas; Karner, Christina; Liesinger, Laura; Birner-Gruenberger, Ruth; Renner, Wilfried; Pichler, Martin; Grillari, Regina; Aigelsreiter, Ariane; Rinner, Beate

ALYREF, a novel factor involved in breast carcinogenesis, acts through transcriptional and post-transcriptional mechanisms selectively regulating the short NEAT1 isoform

ALYREF是一种参与乳腺癌发生的新型因子,它通过转录和转录后机制选择性地调控短链NEAT1亚型。

Klec, Christiane; Knutsen, Erik; Schwarzenbacher, Daniela; Jonas, Katharina; Pasculli, Barbara; Heitzer, Ellen; Rinner, Beate; Krajina, Katarina; Prinz, Felix; Gottschalk, Benjamin; Ulz, Peter; Deutsch, Alexander; Prokesch, Andreas; Jahn, Stephan W; Lellahi, S Mohammad; Perander, Maria; Barbano, Raffaela; Graier, Wolfgang F; Parrella, Paola; Calin, George Adrian; Pichler, Martin

SK119, a Novel Shikonin Derivative, Leads to Apoptosis in Melanoma Cell Lines and Exhibits Synergistic Effects with Vemurafenib and Cobimetinib.

SK119 是一种新型紫草素衍生物,可导致黑色素瘤细胞系凋亡,并与维莫非尼和考比替尼表现出协同作用

Kretschmer Nadine, Durchschein Christin, Hufner Antje, Rinner Beate, Lohberger Birgit, Bauer Rudolf

Drug combination screening as a translational approach toward an improved drug therapy for chordoma

药物组合筛选作为一种转化方法,旨在改进脊索瘤的药物治疗。

Scheipl, Susanne; Barnard, Michelle; Lohberger, Birgit; Zettl, Richard; Brcic, Iva; Liegl-Atzwanger, Bernadette; Rinner, Beate; Meindl, Claudia; Fröhlich, Eleonore